hEGF
SIGMA/E9644 - EGF, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Synonym: Epidermal Growth Factor human; EGF
CAS Number: 62253-63-8
MDL Number: MFCD00132565
Product Type: Chemical
| assay | ≥97% (SDS-PAGE) |
| biological source | human |
| color | white |
| form | lyophilized powder |
| impurities | ≤1 EU/μg endotoxin (EGF) |
| InChI | 1S/C270H401N73O83S7/c1-24 |
| InChI key | GVUGOAYIVIDWIO-UFWWTJHBSA |
| mol wt | ~6 kDa |
| packaging | pkg of 0.2 mg |
| pkg of 0.5 mg | |
| pkg of 5X0.2 mg | |
| potency | 0.08-0.8 ng/mL ED50/EC50 |
| Quality Level | 300 ![]() |
| recombinant | expressed in E. coli |
| SMILES string | S(CC[C@H](NC(=O)[C@@H](NC |
| solubility | water: soluble, clear, colorless |
| storage condition | avoid repeated freeze/thaw cycles |
| storage temp. | −20°C |
| technique(s) | cell culture | mammalian: suitable |
| UniProt accession no. | P01133 ![]() |
| Analysis Note: | The biological activity of this product is measured in a proliferation assay using BALB/MK cells. The EC50 is defined as the effective concentration of growth factor that elicits a 50% increase in cell growth in a cell based bioassay. |
| Application: | This product is used as a mitogen, triggering the cell to commence mitosis, in a variety of cell lines. In tissue cultures, EGF acts to reduce or eliminate the requirement for serum and can be used in conjunction with other media additives and hormones. |
| Biochem/physiol Actions: | Epidermal Growth Factor (EGF) is a small mitogenic polypeptide present throughout a large number of tissues and body fluids in many mammalian species. EGF is a member of a growth factor family characterized by 6 conserved cysteine motifs that form three disulfide bonds. EGF is mitogenic for a variety of epidermal and epithelial cells, including fibroblasts, glial cells, vascular and corneal endothelial cells, bovine granulosa, HeLa cells, SV40-3T3 cells and mammary epithelial cells. Cellular functions affected by EGF: mitosis, ion flux, glucose transport, glycolysis, nucleic acid and protein synthesis, survival, growth, proliferation and differentiation. Biological affects of EGF: inhibition of gastric acid secretion, fetal growth and development and neuromodulation in the central nervous system. Pathways affected by EGF: EGFR signaling, MAPK cascade, PIP, Ca+2 signaling |
| Disclaimer: | This product should be stored at -20°C and will retain activity for two years. After reconstitution, it can be stored at 2-8°C for one month, or frozen in aliquots at -70°C or -20°C for longer periods. |
| Other Notes: | Human EGF (hEGF) is an identical molecule to β-urogastrone, a molecule isolated on the basis of its ability to inhibit gastric acid secretion. EGF is structurally homologous to human transforming growth factor-α, and both exert their actions through EGF receptors. E9644 is the N-terminal methionyl form of natural mature EGF. |
| Packaging: | 0.2 mg in glass bottle |
| Preparation Note: | This product was lyophilized from a 0.2 μm-filtered solution of phosphate buffered saline, at pH 7.4. It should be reconstituted by adding the contents of the vial to 1 mg/mL using 10 mM acetic acid. To dilute to lower concentrations, but no fewer than 10 μg/mL, an addition of 0.1% BSA or HSA will be needed. For use in proliferation assays, further dilute the sample with medium without albumin. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (SDS-PAGE) |
| Storage Temp. | −20°C |
| UNSPSC | 12352202 |

